18 November 2015 12:00-1:30pm ET
Whether this is your first product launch or just the latest of many, obtaining timely FDA approval and considering key commercialization factors early in the development cycle are imperative to the continued success of your business. This webcast will help you navigate the complex US regulatory approval process for new molecular entities and understand the roles of regulatory, clinical, nonclinical and CMC stakeholders, including a discussion of the success factors for appropriate FDA interactions.
You will learn key considerations for outsourcing aspects of product development and regulatory approval. Topics covered also will include critical labeling decisions and other commercial considerations for product success, such as licensing, channel and distribution strategies and reimbursement.
Learning Levels: Intermediate & Advanced
Learning Objectives: Upon the webcast's conclusion, you will be able to:
Who Should Attend?
Regulatory Affairs Professionals Society (RAPS)5635 Fishers Lane, Suite 400Rockville, Maryland 20852
raps@raps.org+1 301 770 2920
JoinMy RAPS DashboardLearn More
About UsTerms of UsePrivacy Policy